Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    India's Draft Biotech Patent Guidelines: What U.S. Applicants Should Know Now

    India's Patent Office has released draft biotechnology examination guidelines that fundamentally reshape how U.S. patent practitioners should approach Indian filings. With strict limits on claim amendments and new standards for diagnostics, efficacy data, and enablement, the window to optimize claims closes at PCT national-phase entry—making pre-filing strategy more critical than ever.
    GlobalIntellectual Property
    Barnes & Thornburg LLP
    Barnes & Thornburg LLP
  • Article

    CCI Again Fines Pharma Company For Anti-Competitive Activities

    The CCI by way of its order dated 28.07.2016 has found the Karnataka Chemists and Druggist Association, Lupin Ltd. and their Office bearers to be in contravention of the provisions of the Competition Act, 2002.
    IndiaAntitrust/Competition Law
    Vaish Associates Advocates
Vaish Associates Advocates
  • Article

    Contract Manufacturing Of Drugs And Cosmetics: Increased Liability For ‘Marketers' From 2021

    On the same day, the Government released another notification amending the Rules with an aim to tighten the regulations in relation to marketing of drugs and medical devices.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Cosmetics Manufacturers May Submit Product Composition Details Before Licensing Their Products

    Central Government, in order to enhance the safety of the cosmetic products, has proposed the product composition details clause shall be mentioned in the approval issued by the licensing authority in the country.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Delhi High Court Permits In-House Expert Of A Contesting Party To Be A Part Of Confidentiality Club

    In the matter of Genentech Inc and others v Drugs Controller General of India and others, CS(OS) 3284 of 2015 (Suit), the Learned Single Judge of the Delhi High Court (Court) has passed an order dated 2 March 2020 (decision)...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Drugs, Medical Devices And Cosmetics Bill, 2022

    The Ministry of Health and Family Welfare ("MHFW"), on 8 July 2022, released a draft of the Drugs, Medical Devices and Cosmetics Bill, 2022 ("Bill") for objections, comments...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Spice Route Legal
    Spice Route Legal
  • Article

    FSSAI Issues Draft Regulations For GMO Food Products

    The Food Safety and Standards Authority of India ("FSSAI") on November 15, 2021, issued Notification F.No.1/Standards/GM Food regulation/FSSAI/20181 which in turn notified the draft Food Safety...
    IndiaFood, Drugs, Healthcare, Life Sciences
    LexCounsel
    LexCounsel
  • Article

    High Levels Of Antibiotic Resistance Found Worldwide: GLASS Report

    On January 29, 2018 World Health Organization (WHO) released the surveillance data of new "Global Antimicrobial Surveillance System (GLASS)" on antibiotic resistance.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Pharma Industry: R&D Efforts To Boost India's Global Standing

    India is a global pharmaceuticals hub and exports medicines to more than 200 nations.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Shardul Amarchand Mangaldas & Co
    Shardul Amarchand Mangaldas & Co
  • Article

    Production In Traditional Area : A Critical Link In GI

    The golden-yellow Muga Silk of Assam has been granted Geographical Indication (GI) registration by the GI Registry in Chennai. The registration was done on the basis of its uniqueness as a silk of given quality and characteristic attributable to the geographical area of Assam since time immemorial.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Protection of Bio-Diversity and IPR

    Environment protection has become one of the major concerns in today’s world of fast technological and economic development. Technology is applied to living species by the inventor to create a commodity out of it for commercial use and to safeguard the inventors’ innovation from unfair commercial use and also to further boost research and development, certain specific rights in the form of intellectual property rights are given as an incentive.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    Raise In Regulatory Fee For Imported Pharma Products

    The development of innovative skills in the technology have led to the betterment of human life in numerous forms.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    The Regional Director, Ministry Of Corporate Affairs Correct In Finding CGMP Pharmaplan Pvt.Ltd Nearly Resembling NNE Pharmaplan India Limited

    In the case of CGMP Pharmaplan Pvt. Ltd v Regional Director, Ministry of Corporate Affairs, the Delhi High Court concurred with the decision of the Regional Director, Ministry of Corporate Affairs (Respondent No.1) which directed CGMP Pharmaplan Pvt. Ltd, to change its name by removing the word "PHARMAPLAN", within a period of three months.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    High Court Grants Permanent Injunction To Mankind Pharma Filed Against Lee Pharma

    On July 19, 2019, Delhi High Court granted permanent injunction against Lee Pharmaceuticals, restraining it from infringing the copyright of Mankind Pharma Ltd.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Nuziveedu Seeds Wins Legal Battle Against US Giant Monsanto!

    It has been a long time since M. Prabhakara Rao, the chairman of Nuziveedu Seeds, was trying to knock down the world's largest seed company "Monsanto Co", in a high-profile conflict over licensing and royalty...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Pharma Hotline - March 09, 2015

    India's Health Ministry has released a draft of the proposed amendments to the Drugs and Cosmetics Act 1940 (Act) for public consultation.
    IndiaIntellectual Property
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    No Booster Dose For The Pharma Sector In The 2022 Budget

    The Pharmaceutical industry is a strategic one which contributes strategically to India's growth story. Globally, India ranks 3rd in terms of pharmaceutical production by volume and is the third largest principal commodity in terms of exports.
    IndiaTax
    Economic Laws Practice
    Economic Laws Practice
  • Article

    A Respite To The Pharmaceutical Manufacturers – Compat Sets Aside CCI Order

    The Competition Appellate Tribunal (COMPAT) on 10 May 2016 has passed a landmark decision setting aside the Competition Commission of India's (CCI) decision in P K Krishnan v Paul Madavana and Ors.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    NPPA Caps Trade Margin For Six Essential Medical Devices

    Read the latest update authored by our Associate Partner, Pradnesh Warke discussing the recent cap by NPPA on the trade margins of the six essential medical devices.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Rejection Of Patent To Sovaldi: Gilead Takes Refuge In Principles Of Natural Justice

    Close on the heels of the US President's historic Republic day visit to India, Gilead, a US based Biopharmaceutical Company, was successful in securing some relief from the Delhi High Court ..
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Showing 81–100 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics